null
ChEBI ID: 17062
| Member | Definition | Role |
|---|---|---|
| 1-(1-phenylcyclopentyl)methylamine | 1-(1-phenylcyclopentyl)methylamine | |
| 1,2-cyclohexanediamine | cyclohexane-1,2-diamine | |
| 2-propylamine | A member of the class of alkylamines that is propane carrying an amino group at position 2. | isopropylamine |
| amantadine | A member of the class of adamantanes that is used as an antiviral and antiparkinson drug. | amantadine |
| cycloate | Cycloate | |
| cyclopropylamine | A primary aliphatic amine that consists of cyclopropane bearing a single amino substituent. | cyclopropylamine |
| dicyclohexylamine | Dicyclohexylamine | |
| dodecylamine | dodecylamine | |
| ethylamine | A two-carbon primary aliphatic amine. | ethylamine |
| hexylamine | A 6-carbon primary aliphatic amine. | 1-hexanamine |
| isoamylamine | A primary aliphatic amine that is butan-1-amine carrying a methyl substituent at position 3. | isopentylamine |
| mecamylamine | Mecamylamine | |
| memantine | A primary aliphatic amine that is the 3,5-dimethyl derivative of 1-aminoadamantane. A low to moderate affinity uncompetitive (open-channel); NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. | memantine |
| methylamine | The simplest of the methylamines, consisting of ammonia bearing a single methyl substituent. | methylamine |
| n-amylamine | A primary aliphatic amine that is n-pentane in which a hydrogen of one of the methyl groups is replaced by an amino group. A water-soluble liquid with boiling point 104degreeC, it is a strong irritant. | pentan-1-amine |
| n-butylamine | A primary aliphatic amine that is butane substituted by an amino group at position 1. | butan-1-amine |
| octylamine | An 8-carbon primary aliphatic amine. | octan-1-amine |
| stearylamine | An 18-carbon primary aliphatic amine. | octadecan-1-amine |
| tert-butylamine | A primary aliphatic amine that is ethylamine substituted by two methyl groups at position 1. | tert-butylamine |
| thioperamide | Thioperamide |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2,862 (26.14) | 18.7374 |
| 1990's | 1,648 (15.05) | 18.2507 |
| 2000's | 2,888 (26.38) | 29.6817 |
| 2010's | 2,848 (26.02) | 24.3611 |
| 2020's | 701 (6.40) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 927 (7.85%) | 5.53% |
| Reviews | 1,161 (9.84%) | 6.00% |
| Case Studies | 518 (4.39%) | 4.05% |
| Observational | 22 (0.19%) | 0.25% |
| Other | 9,174 (77.73%) | 84.16% |